Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1209-1217

  Adams, I B ^a   Compton, D R ^a   Martin, B R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID RECEPTOR; DRONABINOL; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG COMPETITION; DRUG RECEPTOR BINDING; HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANIMALS; ARACHIDONIC ACIDS; AUTORADIOGRAPHY; BRAIN; CANNABINOIDS; CYCLOHEXANOLS; MALE; MICE; MICE, INBRED ICR; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0031935011     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK and Martin BR (1995) Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J Pharmacol Exp Ther 273:1172-1181.
2. Chait LD and Pierri J (1992) Effects of smoked marijuana on human performance: A critical review, in Marijuana/Cannabinoids: Neurobiology and Neurophysiology (Murphy L and Bartke A eds) pp 387-423, CRC Press, Boca Raton, FL.
3. Childers SR, Sexton T and Roy MB (1994) Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol 47:711-715.
4. Collins DR, Pertwee RG and Davies SN (1995) Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol 115:869-870.
5. 9-tetrahdrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586-594.
6. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR (1993) Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
7. Deutsch DG and Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796.
8. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
9. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
10. Dewey WL, Harris LS, Howes JF and Nuite JA (1970) The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther 175:435-442.
11. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K and Devane WA (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90:7656-7660.
12. Felder CC, Joyce K, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma A and Mitchell R (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
13. Fride E and Mechoulam R (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231:313-314.
14. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR and Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
15. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, DeCosta BR and Rice KC (1990) Cannabinoid receptor localization in the brain. Proc Natl Acad Sci USA 87:1932-1936.
16. Jansen EM, Haycock DA, Ward SJ and Seybold VS (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res 575:93-102.
17. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126:125-131.
18. Mackie K, Devane W and Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503.
19. Mailleux P, Parmentier M and Vanderhaeghen J-J (1992) Distribution of cannabinoid receptor messenger RNA in the human brain: An in situ hybridization histochemistry with oligonucleotides. Neurosci Lett 143:200-204.
20. Mailleux P and Vanderhaegen J-J (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
21. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
22. Munson PJ and Rodbard D (1980) LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
23. 9-tetrahydrocannabinol for intravenous injection. J Pharm Pharmacol 25:344.
24. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, Australia.
25. Pertwee RG (1972) The ring test: A quantitative method for assessing the "cataleptic' effect of cannabis in mice. Br J Pharmacol 46:753-763.
26. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC and Le Fur G (1994) SR141716A a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
27. 3H]-SR 141716A a selective brain (CB1) cannabinoid receptor antagonist in rodent brain. Life Sci 58:1239-1247.
28. 9-Tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR 141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboximide hydrochloride]. Biochem Pharmacol 51:669-676.
29. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R and Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227.
30. Souilhac J, Poncelet M, Rinaldi-Carmona M, Le Fur G and Soubrie P (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol Biochem Behav 51:3-7.
31. Terranova J-P, Michaud J-C, Le Fur G and Soubrie P (1995) Inhibition of long-term potentiation in rat hippocampal slices by anadamide and win55212-2: Reversal by sr141716A, a selective antagonist of cb1 cannabinoid receptors. NauynSchmiedeberg Arch Pharmacol 352:576-579.
32. 9-THC-DMH. J Pharmacol Exp Ther 263:1383-1390.
33. Varga K, Lake K, Martin B and Kunos G (1995) Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279-283.
34. Westlake TM and Howlett AC (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and alzheimer's brains. Neuroscience 63:637-652.
35. Wiley J, Balster R and Martin B (1995a) Discriminative stimulus effects of anandamide in rats. Eur J Pharmacol 276:49-54.
36. 9-tetrahydrocannabinol in rats and rhesus monkeys. J Pharmacol Exp Ther 275:1-6.
37. Willoughby KA, Moore SF, Martin BR and Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243-247.